Drug-eluting Stent thrombosis during perioperative period

International Heart Journal

Volumn 49, Issue 2, 2008, Pages 135-142

  Rhee, Sang Jae ^a   Yun, Kyeong Ho ^a   Lee, Sang Rok ^b   Chae, Jei Keon ^b   Nam, Chang Wook ^c   Jun, Dong Hwan ^c   Jeong, Jin Won ^a  

^a Wonkwang University   (South Korea)

^b Chonbuk National University Medical School   (South Korea)

^c Keimyung University   (South Korea)

Author keywords

Drug eluting stents; Perioperative care; Stent thrombosis

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL;

ABDOMINAL SURGERY; ADULT; AGED; ARTICLE; BRAIN SURGERY; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; CORONARY ARTERY THROMBOSIS; CORONARY STENT; DRUG ELUTING STENT; EMERGENCY SURGERY; FATALITY; FEMALE; HEART DISEASE; HEART INFARCTION; HEART SURGERY; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; ORTHOPEDIC SURGERY; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PERIOPERATIVE PERIOD; PREDICTION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK REDUCTION; SPINE SURGERY; TRANSURETHRAL RESECTION; BLOOD VESSEL PROSTHESIS; INCIDENCE; MIDDLE AGED; RISK FACTOR;

AGED; BLOOD VESSEL PROSTHESIS; CORONARY THROMBOSIS; DRUG-ELUTING STENTS; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PERIOPERATIVE CARE; PLATELET AGGREGATION INHIBITORS; RISK FACTORS;

EID: 45549106411     PISSN: 13492365     EISSN: 13493299     Source Type: Journal    
DOI: 10.1536/ihj.49.135     Document Type: Article

References (22)

1. Iakovou I, Schmidt T, Bonizzoni E, et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 2005; 293: 2126-30.
2. Katayama T, Yamamoto T, Iwasaki Y, Yano K. Two cases of very late stent thrombosis after implantation of a sirolimus-eluting stent presenting as AMI. Int Heart J 2007; 48: 393-7.
3. Yang J, Wang N, Zhang X, et al. Late angiographic stent thrombosis in a drug-eluting stent that occurred 20 months after premature discontinuation of clopidogrel administration. Int Heart J 2006; 47: 707-13.
4. Fujii K, Carlier SG, Mintz GS, et al. Stent underexpansion and residual reference segment stenosis are related to stent thrombosis after sirolimus-eluting stent implantation: an intravascular ultrasound study. J Am Coll Cardiol 2005; 45: 995-8.
5. Mehilli J, Dibra A, Kastrati A, et al. Randomized trial of paclitaxel- and sirolimus-eluting stents in small coronary vessels. Eur Heart J 2006; 27: 260-6.
6. Ong AT, Hoye A, Aoki J, et al. Thirty-day incidence and six-month clinical outcome of thrombotic stent occlusion after bare-metal, sirolimus, or paclitaxel stent implantation. J Am Coll Cardiol 2005; 45: 947-53.
7. Ong AT, McFadden EP, Regar E, de Jaegere PP, van Domburg RT, Serruys PW. Late angiographic stent thrombosis (LAST) events with drug-eluting stents. J Am Coll Cardiol 2005; 45: 2088-92.
8. Park DW, Park SW, Park KH, et al. Frequency of and risk factors for stent thrombosis after drug-eluting stent implantation during long-term follow-up. Am J Cardiol 2006; 98: 352-6.
9. Moreno R. Fernandez C, Hernández R, et al. Drug-eluting stent thrombosis: results from a pooled analysis including 10 randomized studies. J Am Coll Cardiol 2005; 45: 954-9.
10. Wilson SH, Fasseas P, Orford JL, et al. Clinical outcome of patients undergoing non-cardiac surgery in the two months following coronary stenting. J Am Coll Cardiol 2003; 42: 234-40.
11. Sharma AK, Ajani AE, Hamwi SM, et al. Major noncardiac surgery following coronary stenting: when is it safe to operate? Catheter Cardiovasc Interv 2004; 63: 141-5.
12. Reddy PR, Vaitkus PT. Risks of noncardiac surgery after coronary stenting. Am J Cardiol 2005; 95: 755-7.
13. Grines CL, Bonow RO, Casey DE Jr, et al. Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, with representation from the American College of Physicians. Circulation 2007; 115: 813-8.
14. Brilakis ES, Banerjee S, Berger PB. Perioperative management of patients with coronary stents. J Am Coll Cardiol 2007; 49: 2145-50.
15. Schouten O, van Domburg RT, Bax JJ, et al. Noncardiac surgery after coronary stenting: early surgery and interruption of antiplatelet therapy are associated with an increase in major adverse cardiac events. J Am Coll Cardiol 2007; 49: 122-4.
16. Eagle KA, Beiger PB, Calkins H, et al. ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery - executive summary a report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). Circulation 2002; 105: 1257-67.
17. Sousa JE, Costa MA, Farb A, et al. Images in cardiovascular medicine. Vascular healing 4 years after the implantation of sirolimus-eluting stent in humans: a histopathological examination. Circulation 2004; 110: e5-6.
18. Yan BP, Gurvitch R, Ajani AE. Double jeopardy: balance between bleeding and stent thrombosis with prolonged dual antiplatelet therapy after drug-eluting stent implantation. Cardiovasc Revasc Med 2006; 7: 155-8.
19. Nasser M, Kapeliovich K Markiewicz W. Late thrombosis of sirolimus-eluting stents following noncardiac surgery. Catheter Cardiovasc Interv 2005; 65: 516-9.
20. Brilakis ES, Banerjee S, Berger PB. The risk of drug-eluting stent thrombosis with noncardiac surgery. Curr Cardiol Rep 2007; 9: 406-11.
21. Roiron C, Sanchez P, Bouzamondo A, Lechat P, Montalescot G. Drug eluting stents: an updated meta-analysis of randomised controlled trials. Heart 2006; 92: 641-9.
22. Ong AT, Serruys PW. Drug-eluting stents: current issues. Tex Heart Inst J 2005; 32: 372-7.